These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
74 related articles for article (PubMed ID: 19701869)
21. Apoptotic markers p53, Bcl-2 and Bax in primary lung cancer. Porebska I; Wyrodek E; Kosacka M; Adamiak J; Jankowska R; Harłozińska-Szmyrka A In Vivo; 2006; 20(5):599-604. PubMed ID: 17091766 [TBL] [Abstract][Full Text] [Related]
22. Prognostic value of Bax, Bcl-2, p53, and TUNEL staining in patients with radically resected ampullary carcinoma. Santini D; Tonini G; Vecchio FM; Borzomati D; Vincenzi B; Valeri S; Antinori A; Castri F; Coppola R; Magistrelli P; Nuzzo G; Picciocchi A J Clin Pathol; 2005 Feb; 58(2):159-65. PubMed ID: 15677536 [TBL] [Abstract][Full Text] [Related]
23. Pineal parenchymal tumors--utility of immunohistochemical markers in prognostication. Arivazhagan A; Anandh B; Santosh V; Chandramouli BA Clin Neuropathol; 2008; 27(5):325-33. PubMed ID: 18808064 [TBL] [Abstract][Full Text] [Related]
24. Prognostic significance of clinical parameters and biological markers in patients with squamous cell carcinoma of the head and neck treated with concurrent chemoradiotherapy. Homma A; Furuta Y; Oridate N; Nakano Y; Kohashi G; Yagi K; Nagahashi T; Yagi K; Nagahashi T; Fukuda S; Inoue K; Inuyama Y Clin Cancer Res; 1999 Apr; 5(4):801-6. PubMed ID: 10213215 [TBL] [Abstract][Full Text] [Related]
25. Utility of Ki67 immunostaining in the grading of pineal parenchymal tumours: a multicentre study. Fèvre-Montange M; Vasiljevic A; Frappaz D; Champier J; Szathmari A; Aubriot Lorton MH; Chapon F; Coulon A; Quintin Roué I; Delisle MB; Figarella-Branger D; Laquerrière A; Miquel C; Michiels JF; Péoch M; Polivka M; Fauchon F; Jouvet A Neuropathol Appl Neurobiol; 2012 Feb; 38(1):87-94. PubMed ID: 21696422 [TBL] [Abstract][Full Text] [Related]
26. Bax protein expression in colorectal cancer: association with p53, bcl-2 and patterns of relapse. Giatromanolaki A; Sivridis E; Stathopoulos GP; Fountzilas G; Kalofonos HP; Tsamandas A; Vrettou E; Scopa C; Polychronidis A; Simopoulos K; Koukourakis MI Anticancer Res; 2001; 21(1A):253-9. PubMed ID: 11299743 [TBL] [Abstract][Full Text] [Related]
27. Increased Bax/Bcl-2 ratio up-regulates caspase-3 and increases apoptosis in the thymus of patients with myasthenia gravis. Salakou S; Kardamakis D; Tsamandas AC; Zolota V; Apostolakis E; Tzelepi V; Papathanasopoulos P; Bonikos DS; Papapetropoulos T; Petsas T; Dougenis D In Vivo; 2007; 21(1):123-32. PubMed ID: 17354625 [TBL] [Abstract][Full Text] [Related]
28. Expression of apoptosis markers in the retinas of human subjects with diabetes. Abu-El-Asrar AM; Dralands L; Missotten L; Al-Jadaan IA; Geboes K Invest Ophthalmol Vis Sci; 2004 Aug; 45(8):2760-6. PubMed ID: 15277502 [TBL] [Abstract][Full Text] [Related]
29. Bax, bcl-2 and c-kit expression in non-small-cell lung cancer and their effects on prognosis. Yaren A; Oztop I; Kargi A; Ulukus C; Onen A; Sanli A; Binicier O; Yilmaz U; Alakavuklar M Int J Clin Pract; 2006 Jun; 60(6):675-82. PubMed ID: 16805752 [TBL] [Abstract][Full Text] [Related]
32. Prognostic value of Bak expression in oral tongue squamous cell carcinomas. Xie X; Clausen OP; Boysen M Oncol Rep; 2003; 10(2):369-74. PubMed ID: 12579274 [TBL] [Abstract][Full Text] [Related]
33. Immunohistochemical characterization of pineal parenchymal tumors using novel monoclonal antibodies to the pineal body. Yamane Y; Mena H; Nakazato Y Neuropathology; 2002 Jun; 22(2):66-76. PubMed ID: 12075938 [TBL] [Abstract][Full Text] [Related]
34. [Protein expression of p53, bcl-2, and bax in adenoid cystic carcinoma of lacrimal gland]. You JQ; Wang P Zhonghua Yi Xue Za Zhi; 2008 Jul; 88(28):1978-82. PubMed ID: 19062739 [TBL] [Abstract][Full Text] [Related]
35. Comparison of DNA ploidy, histologic, and immunohistochemical findings with clinical outcome in inflammatory myofibroblastic tumors. Hussong JW; Brown M; Perkins SL; Dehner LP; Coffin CM Mod Pathol; 1999 Mar; 12(3):279-86. PubMed ID: 10102613 [TBL] [Abstract][Full Text] [Related]
36. Analysis of Bax and Bcl-2 expression in p53-immunopositive breast cancers. Krajewski S; Thor AD; Edgerton SM; Moore DH; Krajewska M; Reed JC Clin Cancer Res; 1997 Feb; 3(2):199-208. PubMed ID: 9815673 [TBL] [Abstract][Full Text] [Related]
37. Apoptosis-associated markers and clinical outcome in human oral squamous cell carcinomas. Kato K; Kawashiri S; Yoshizawa K; Kitahara H; Yamamoto E J Oral Pathol Med; 2008 Jul; 37(6):364-71. PubMed ID: 18410312 [TBL] [Abstract][Full Text] [Related]
38. Expression of cell cycle and apoptosis regulatory proteins in keratoacanthoma and squamous cell carcinoma. Batinac T; Zamolo G; Coklo M; Hadzisejdic I; Stemberger C; Zauhar G Pathol Res Pract; 2006; 202(8):599-607. PubMed ID: 16781827 [TBL] [Abstract][Full Text] [Related]
39. Immunofluorometric study of Bcl-2 and Bax expression in clinical fresh tumor samples from breast cancer patients. Martínez-Arribas F; Núñez-Villar MJ; Lucas AR; Sánchez J; Tejerina A; Schneider J Anticancer Res; 2003; 23(1B):565-8. PubMed ID: 12680147 [TBL] [Abstract][Full Text] [Related]
40. Correlation of Bcl-2 and p53 expression in primary breast tumors and corresponding metastatic lymph nodes. Arun B; Kilic G; Yen C; Foster B; Yardley D; Gaynor R; Ashfaq R Cancer; 2003 Dec; 98(12):2554-9. PubMed ID: 14669273 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]